Virax Biolabs Group Limited () SEC Filings https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/rss Virax Biolabs Group Limited () - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/viraxbiolabs/files/theme/images/logo-300px.png Virax Biolabs Group Limited Logo Equisolve Investor Relations Suite <![CDATA[F-3 - Registration statement by foreign private issuers]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-316130/0001193125-26-316130.pdf Fri, 24 Jul 26 16:21:44 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-316130/0001193125-26-316130.pdf <![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-305400/0001193125-26-305400.pdf Thu, 16 Jul 26 07:32:02 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-305400/0001193125-26-305400.pdf <![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-300880/0001193125-26-300880.pdf Fri, 10 Jul 26 16:07:31 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-300880/0001193125-26-300880.pdf <![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-299132/0001193125-26-299132.pdf Thu, 09 Jul 26 07:34:24 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-299132/0001193125-26-299132.pdf <![CDATA[20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-295158/0001193125-26-295158.pdf Mon, 06 Jul 26 06:03:45 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-295158/0001193125-26-295158.pdf <![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-281196/0001193125-26-281196.pdf Wed, 24 Jun 26 16:47:16 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-281196/0001193125-26-281196.pdf <![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-268604/0001193125-26-268604.pdf Fri, 12 Jun 26 09:24:58 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-268604/0001193125-26-268604.pdf <![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-237882/0001193125-26-237882.pdf Tue, 26 May 26 07:33:34 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-237882/0001193125-26-237882.pdf <![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-236980/0001193125-26-236980.pdf Fri, 22 May 26 16:26:25 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001193125-26-236980/0001193125-26-236980.pdf <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001172661-26-002143/0001172661-26-002143.pdf Fri, 15 May 26 11:15:29 -0400 https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0001172661-26-002143/0001172661-26-002143.pdf